ITGR
Integer Holdings Corporation
NYSE · Healthcare · Medical - Devices · US
$126.50
+0.80%Year over year
Reported trailing growth
- Revenue
- +2.9%
- EBITDA
- +6.3%
- EBIT
- -20.5%
- EPS
- +52.5%
- Free cash flow
- -6.9%
- Operating cash flow
- -2.1%
Forward estimates
Based on analyst estimates
- Revenue
- +1.5%
- EBITDA
- +38.0%
- EPS
- +81.5%
Three-year CAGR
- Revenue
- +11.5%
- EBITDA
- +9.8%
- EBIT
- +22.9%
- Net income
- +15.7%
- EPS
- +14.5%
- Free cash flow
- +36.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026